IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

60 Degrees Pharma Inc (SXTP)

CUSIP: 83006G500 | NYSE | Healthcare · Biotechnology | Micro Cap | 11 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AIntracoastal Capital LLC390,34210.0%New 5%+ stakeSep 30, 2026No 13F filer matched
13GLind Global Fund III LP191,5715.5%New 5%+ stakeJul 31, 2026

Institutional Holders — Q3 2026

Kathmere Capital Management, LLC390,953
0.0% of portfolio›$520.0K
Geode Capital Management, LLC14,551
0.0% of portfolio›$19.4K
UBS Group AG13,526
0.0% of portfolio›$18.0K
Barclays PLC1,475
0.0% of portfolio›$2.0K
StyleTurnoverLocationFiled
Kathmere Capital Management, LLC
390,953$520.0K0.0%ETFLowWayne, PA2026-10-20
Geode Capital Management, LLC
14,551$19.4K0.0%IndexVery LowBoston, MA2026-11-06
UBS Group AG
13,526$18.0K0.0%CoreMediumZurich, Switzerland2026-11-10
Barclays PLC
1,475$2.0K0.0%GrowthMediumLondon, United Kingdom2026-11-06
No 13F filer matched
13G/AIntracoastal Capital LLC390,342
10.0% of class · Sep 30, 2026New 5%+ stake
No 13F filer matched
13GLind Global Fund III LP191,571
5.5% of class · Jul 31, 2026New 5%+ stake
No 13F filer matched